LDCT Screening for Lung Cancer? This Aid Can Help Decide
Web-based decision tool in development to help high-risk patients decide if they want to undergo low dose CT screening for lung cancer.
A web-based decision-making tool for lung cancer screening (LCS) may help patients at high risk for lung cancer from smoking, say researchers from the University of Kentucky and the University of Miami.
While the National Lung Screening Trial (NLST) found that low-dose CT screening (LDCT) among people at high risk for lung cancer showed a 20 percent relative reduction in lung cancer mortality as compared to chest radiography, the report also noted substantial risks and limitations to LDCT, which include overdiagnosis and high false positive rates. The concern now is that patients may not be properly equipped to decide for or against LCS. The researchers’ proposed project is to develop a web-based decision aid that will help patients decide whether to undergo LCS.
“Screening is for asymptomatic healthy people to find out there’s something wrong,” Jamie Studts, PhD, researcher at the University of Kentucky, said in a release. “You are committing to a series of events that will lead to either learning you don’t have cancer, or detecting it and treating it.”[[{"type":"media","view_mode":"media_crop","fid":"26735","attributes":{"alt":"low dose lung CT","class":"media-image media-image-right","id":"media_crop_7067090008529","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2526","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 142px; width: 150px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
The decision-making aid will provide information to the patients and empower the patients to talk to their physicians and make their decisions with the relevant information. A third objective involves clarifying the patient’s values: their personal preferences regarding screening and treatment. “The goal is to help people interpret what they learn in the context of what’s important to them regarding their goals in health,” Studts said. “They will learn about lung cancer screening options, benefits, harms, and uncertainties associated with the modality.”
A clinical trial for the decision aid will be held in Florida and Kentucky.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
